Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
Arbutus Biopharma Corp reports 2023 executive compensation
By ExecPay News
Published: April 10, 2024
Arbutus Biopharma Corp reported fiscal year 2023 executive compensation information on April 10, 2024.
In 2023, four executives at Arbutus Biopharma Corp received on average a compensation package of $2.1M, a 22% increase compared to previous year.
Average pay of disclosed executives at Arbutus Biopharma Corp
William H. Collier, Chief Executive Officer, received $3.4M in total, which increased by 28% compared to 2022. 56% of Collier's compensation, or $1.9M, was in option awards. Collier also received $637K in salary, $628K in stock awards, as well as $224K in other compensation.
Elizabeth Howard, General Counsel, received a compensation package of $1.8M. 44% of the compensation package, or $803K, was in other compensation.
Michael J. McElhaugh, Chief Executive Officer, earned $1.6M in 2023, a 23% increase compared to previous year.
Michael Sofia, Chief Scientific Officer, received $1.6M in 2023, which increases by 29% compared to 2022.
Related executives
You may also like
Source: SEC filing on April 10, 2024.